Atom Grants
Discover

    Neurology Ionis Young Investigator Grant (YIG)

    Supports early-career researchers in advancing diagnosis, understanding, and patient care for Angelman Syndrome through innovative translational or clinical research.

    Overview
    Eligibility
    Sources (3)
    Similar Grants
    Researchers

    Funder: Ionis Pharmaceuticals

    Due Dates: May 29, 2026 (Full application deadline)

    Funding Amounts: $50,000 per year, up to 2 years (total $100,000 possible); 2 awards annually

    Summary: Supports early-career researchers conducting innovative research on Angelman Syndrome to advance diagnosis, understanding, and patient care.

    Key Information: Applications must be submitted by email; late or incomplete applications are not considered.


    Description

    This opportunity supports early-career investigators (fellows, residents, or junior faculty) engaged in high-quality, innovative research on Angelman Syndrome. The program aims to foster the development of future leaders in neurology by funding translational, clinical, or applied research that advances understanding of Angelman Syndrome, enables earlier diagnosis, characterizes the disease across age groups and genetic subtypes, identifies undiagnosed or misdiagnosed patients, and improves patient care. Research must be conducted at an eligible academic or non-profit institution under the supervision of an experienced mentor, with an expectation of external data presentation or publication within two years.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.